<?xml version="1.0" encoding="UTF-8"?>
<p id="Par22">We first assessed the effect of oral administration of 
 <italic>L. paracasei</italic> CNCM I-1518 on secondary meningococcal infection. Mice were infected intranasally with H3N2 influenza virus at day 0 and superinfected intranasally with 
 <italic>N. meningitidis</italic> seven days later (Fig. 
 <xref rid="Fig1" ref-type="fig">1a</xref>).
</p>
